These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 3049820
21. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity. Reiter Z. Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640 [Abstract] [Full Text] [Related]
22. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. Warren HS, Kinnear BF, Kastelein RL, Lanier LL. J Immunol; 1996 May 01; 156(9):3254-9. PubMed ID: 8617947 [Abstract] [Full Text] [Related]
23. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation. Sayers TJ, Mason AT, Ortaldo JR. J Immunol; 1986 Mar 15; 136(6):2176-80. PubMed ID: 3081640 [Abstract] [Full Text] [Related]
25. Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2. Ohlén C, Bejarano MT, Grönberg A, Torsteinsdottir S, Franksson L, Ljunggren HG, Klein E, Klein G, Kärre K. J Immunol; 1989 May 01; 142(9):3336-41. PubMed ID: 2468716 [Abstract] [Full Text] [Related]
26. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. Lebow LT, Jewett A, Bonavida B. J Immunol; 1993 Jan 01; 150(1):320-9. PubMed ID: 8417130 [Abstract] [Full Text] [Related]
27. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines. Sun R, Li AL, Wei HM, Tian ZG. Cell Res; 2004 Feb 01; 14(1):67-73. PubMed ID: 15040892 [Abstract] [Full Text] [Related]
28. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event. Steele TA, Brahmi Z. J Immunol; 1988 Nov 01; 141(9):3164-9. PubMed ID: 3262683 [Abstract] [Full Text] [Related]
30. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. Cesano A, Visonneau S, Clark SC, Santoli D. J Immunol; 1993 Sep 15; 151(6):2943-57. PubMed ID: 8104216 [Abstract] [Full Text] [Related]
33. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals. Shipp MA, Reinherz EL. J Immunol; 1987 Oct 01; 139(7):2143-8. PubMed ID: 2821108 [Abstract] [Full Text] [Related]
34. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. Rook AH, Hooks JJ, Quinnan GV, Lane HC, Manischewitz JF, Macher AM, Masur H, Fauci AS, Djeu JY. J Immunol; 1985 Mar 01; 134(3):1503-7. PubMed ID: 3918102 [Abstract] [Full Text] [Related]
36. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production. Watanabe M, Fenton RG, Wigginton JM, McCormick KL, Volker KM, Fogler WE, Roessler PG, Wiltrout RH. J Immunol; 1999 Aug 15; 163(4):1943-50. PubMed ID: 10438930 [Abstract] [Full Text] [Related]
37. Modulation of interferon-induced NK cells by interleukin 2 and cAMP. Chun M, Hoffmann MK. Lymphokine Res; 1982 Aug 15; 1(4):91-8. PubMed ID: 6097776 [Abstract] [Full Text] [Related]
40. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Perussia B. J Immunol; 1998 Oct 01; 161(7):3493-500. PubMed ID: 9759869 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]